CSF Aβ40 and P-tau181 might differentiate atypical from typical AD phenotypes: preliminary evidence

Verde, F; Aiello, EN; Grigoli, EG; Milone, I; Dubini, A; Ratti, A; Poletti, B; Ticozzi, N; Silani, V

Aiello, EN (通讯作者)，IRCCS Ist Auxol Italiano, Dept Neurol, Lab Neurosci, Piazzale Brescia 20, I-20149 Milan, MI, Italy.;Aiello, EN (通讯作者)，IRCCS Ist Auxol Italiano, Lab Neurosci, Piazzale Brescia 20, I-20149 Milan, MI, Italy.;Aiello, EN (通讯作者)，Univ Milano Bicocca, Sch Med & Surg, PhD Program Neurosci, Via Cadore 48, I-20900 Monza, MB, Italy.

NEURODEGENERATIVE DISEASES, 2023; 22 (2): 83

Abstract

Objectives. This study aimed at testing whether CSF levels of amyloid beta 42 (A beta 42), A beta 40, total tau and phosphorylated tau (P-tau181) indi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索